Features Screener Stocks Charts
Sign In Sign Up

ALKEM Cash Flow Statement

NSE:ALKEM | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.96x

ALKEM's operating cash flow covered 96% of net income in FY 2024. Some earnings may be tied up in working capital.

Free Cash Flow

₹16.89B

ALKEM's free cash flow was ₹16.89B in FY 2024, up 118.7% from FY 2022.

Dividend Coverage

3.1x

ALKEM's free cash flow covered dividends 3.1x in FY 2024, leaving room for reinvestment or debt reduction.

CapEx Intensity

13.3%

Capital expenditure was 13.3% of operating cash flow in FY 2024 for ALKEM, indicating a capital-light business.

2-year ALKEM cash flow snapshot

Hover the chart icon for YoY change.

FY 2022 - FY 2024
Item Chart 2022 2024
Net Income 18.44B 20.23B
Cash flow Operating Activities 11.11B 19.48B
Investments in PPE -3.39B -2.59B
Cash flow Investing Activities -14.35B -10.09B
Dividend Paid -4.22B -5.40B
Cash flow Financing Activities 3.80B -11.45B
Cash at beginning of period 1.74B 2.74B
Cash at end of period 2.32B 663.10M
Free Cash Flow 7.72B 16.89B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2024